Ilika “well-funded to get through and into commercialisation of Stereax and to fund Goliath” says Baden Hill (LON:IKA) 26 January 2022
Anexo Group’s housing disrepair business to be a significant contributor to revenues in 2022 and beyond (LON:ANX) 26 January 2022
City of London Investment Group “a reliable business, well controlled and delivering an attractive dividend” says Zeus Capital (LON:CLIG) 25 January 2022
Poolbeg Pharma very excited about the potential of University of Warwick deal (LON:POLB) 21 January 2022
Diverse Income Trust Plc reports 8.5% H1 returns and review of redemptions and discount 13 February 2026
CQS Natural Resources Growth & Income Fund: Why Energy Scarcity and M&A Are Driving the Next Commodities Boom (Video) 11 February 2026
DCC Plc expects good operating profit growth and significant strategic progress in 2025 5 February 2025
Vistry Group PLC (VTY.L) Stock Analysis: Navigating Challenges in the Residential Construction Sector 16 February 2026
TESCO PLC (TSCO.L) Stock Analysis: Navigating the Consumer Defensive Sector with Resilient Performance 16 February 2026
Ilika “well-funded to get through and into commercialisation of Stereax and to fund Goliath” says Baden Hill (LON:IKA) 26 January 2022
Anexo Group’s housing disrepair business to be a significant contributor to revenues in 2022 and beyond (LON:ANX) 26 January 2022
City of London Investment Group “a reliable business, well controlled and delivering an attractive dividend” says Zeus Capital (LON:CLIG) 25 January 2022
Poolbeg Pharma very excited about the potential of University of Warwick deal (LON:POLB) 21 January 2022
Diverse Income Trust Plc reports 8.5% H1 returns and review of redemptions and discount 13 February 2026
CQS Natural Resources Growth & Income Fund: Why Energy Scarcity and M&A Are Driving the Next Commodities Boom (Video) 11 February 2026
DCC Plc expects good operating profit growth and significant strategic progress in 2025 5 February 2025
Vistry Group PLC (VTY.L) Stock Analysis: Navigating Challenges in the Residential Construction Sector 16 February 2026
TESCO PLC (TSCO.L) Stock Analysis: Navigating the Consumer Defensive Sector with Resilient Performance 16 February 2026
Evotec SE (EVO) Stock Analysis: Evaluating an 83.88% Potential Upside Despite Recent Challenges 9 December 2025
Novavax, Inc. (NVAX) Investor Outlook: Exploring an 86.82% Potential Upside in the Biotechnology Sector 9 December 2025
Liquidia Corporation (LQDA) Stock Analysis: Exploring a Potential 25.68% Upside in the Biotech Sector 9 December 2025
Amphastar Pharmaceuticals (AMPH) Stock Analysis: Uncovering a 21.93% Potential Upside 9 December 2025
agilon health, inc. (AGL) Stock Analysis: Navigating a 39% Potential Upside in Healthcare 9 December 2025
Azenta, Inc. (AZTA) Stock Analysis: Unveiling a 13.65% Potential Upside Amidst Steady Growth 9 December 2025
Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis: Evaluating the 121.70% Revenue Growth in the Booming Biotech Market 9 December 2025
Establishment Labs Holdings Inc (ESTA) Stock Analysis: Healthcare Innovator with 33.7% Revenue Growth 9 December 2025
Structure Therapeutics Inc. (GPCR) Stock Analysis: A Closer Look at Its 6.51% Potential Upside 9 December 2025
Clover Health Investments (CLOV): A 26% Upside Potential in the Healthcare Plans Sector 9 December 2025
Tarsus Pharmaceuticals, Inc. (TARS) Stock Analysis: Eyeing Growth with a Promising 146.70% Revenue Surge 9 December 2025
Harrow, Inc. (HROW) Stock Analysis: Eyeing a 48.78% Potential Upside in the Competitive Ophthalmic Market 9 December 2025
AtriCure, Inc. (ATRC) Stock Analysis: Strong Buy Ratings and a 32.68% Potential Upside 9 December 2025
Pacira BioSciences, Inc. (PCRX) Stock Analysis: Exploring a 21.68% Potential Upside in the Healthcare Sector 9 December 2025
NeoGenomics, Inc. (NEO) Stock Analysis: Exploring a 14.75% Potential Upside in the Diagnostics Sector 9 December 2025
Viridian Therapeutics, Inc. (VRDN): Investor Outlook with a Promising 24.88% Potential Upside 9 December 2025
Wave Life Sciences Ltd. (WVE) Stock Analysis: Biotechnology Innovator with a 29.59% Upside Potential 9 December 2025
Recursion Pharmaceuticals, Inc. (RXRX) Stock Analysis: Exploring a 31.40% Potential Upside 9 December 2025
Palace Capital good clarity in NAV and EPS over and above the market (Analyst Interview) 9 December 2021
Pennant International pipeline update underpins 2022 forecasts and supports 2023 (Interview) 7 December 2021
Hardide healthy pipeline of exciting opportunities in current and new markets (Interview) 7 December 2021
Scottish Mortgage Investment Trust Plc appoints Christopher Samuel as an independent NED 8 November 2024
Ilika “well-funded to get through and into commercialisation of Stereax and to fund Goliath” says Baden Hill (LON:IKA) 26 January 2022
Anexo Group’s housing disrepair business to be a significant contributor to revenues in 2022 and beyond (LON:ANX) 26 January 2022
City of London Investment Group “a reliable business, well controlled and delivering an attractive dividend” says Zeus Capital (LON:CLIG) 25 January 2022
Poolbeg Pharma very excited about the potential of University of Warwick deal (LON:POLB) 21 January 2022
Diverse Income Trust Plc reports 8.5% H1 returns and review of redemptions and discount 13 February 2026
CQS Natural Resources Growth & Income Fund: Why Energy Scarcity and M&A Are Driving the Next Commodities Boom (Video) 11 February 2026
Vistry Group PLC (VTY.L) Stock Analysis: Navigating Challenges in the Residential Construction Sector 16 February 2026
TESCO PLC (TSCO.L) Stock Analysis: Navigating the Consumer Defensive Sector with Resilient Performance 16 February 2026
